NCT05384652View on ClinicalTrials.gov

Simultaneous Quantification of Liver Fat Content, Fatty Acid Composition, and Fibrosis Using Spin-lock MRI for Steatohepatitis Assessment

Not yet recruitingOBSERVATIONAL

Enrollment

140

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

June 30, 2027

Conditions

Non-alcoholic Fatty Liver Disease (NAFLD)Non-alcoholic Steatohepatitis (NASH)

Trial Locations (1)

Unknown

The Chinese University of Hong Kong, Prince of Wale Hospital, Hong Kong

All Listed Sponsors

lead

Chinese University of Hong Kong

OTHER

NCT05384652 - Simultaneous Quantification of Liver Fat Content, Fatty Acid Composition, and Fibrosis Using Spin-lock MRI for Steatohepatitis Assessment | Biotech Hunter | Biotech Hunter